Education
About Us
Working with TipRanks
Follow Us
Torii Pharmaceutical Co (JP:4551)
:4551
RESEARCH TOOLSreports
4551 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥3,105.00 - ¥6,420.00
Previous CloseN/A
Volume83.70K
Average Volume (3M)142.62K
Market Cap
¥178.11B
Enterprise Value¥42.70B
Total Cash (Recent Filing)¥43.30B
Total Debt (Recent Filing)¥429.00M
Price to Earnings (P/E)32.1
Beta0.71
Next Earnings
Jul 31, 2025EPS EstimateN/A
Last Dividend Ex-Date
Dec 27, 2024Dividend Yield1.89%
Share Statistics
EPS (TTM)197.61
Shares Outstanding28,800,000
10 Day Avg. Volume53,880
30 Day Avg. Volume142,623
Financial Highlights & Ratios
PEG Ratio1.23
Price to Book (P/B)0.69
Price to Sales (P/S)0.00
P/FCF Ratio38.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Torii Pharmaceutical Co News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.73%
Mutual Funds
― Other Institutional Investors
96.78% Public Companies and
Individual Investors
4551 FAQ
What was Torii Pharmaceutical Co ’s price range in the past 12 months?
Torii Pharmaceutical Co lowest stock price was ¥3105.00 and its highest was ¥6420.00 in the past 12 months.
What is Torii Pharmaceutical Co ’s market cap?
Torii Pharmaceutical Co ’s market cap is ¥178.11B.
When is Torii Pharmaceutical Co ’s upcoming earnings report date?
Torii Pharmaceutical Co ’s upcoming earnings report date is Jul 31, 2025 which is in 40 days.
How were Torii Pharmaceutical Co ’s earnings last quarter?
Torii Pharmaceutical Co released its earnings results on Apr 25, 2025. The company reported ¥49.51 earnings per share for the quarter, beating the consensus estimate of N/A by ¥49.51.
Is Torii Pharmaceutical Co overvalued?
According to Wall Street analysts Torii Pharmaceutical Co ’s price is currently Overvalued.
Does Torii Pharmaceutical Co pay dividends?
Torii Pharmaceutical Co pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 1.89%. See more information on Torii Pharmaceutical Co dividends here
What is Torii Pharmaceutical Co ’s EPS estimate?
Torii Pharmaceutical Co ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Torii Pharmaceutical Co have?
Torii Pharmaceutical Co has 28,800,000 shares outstanding.
What happened to Torii Pharmaceutical Co ’s price movement after its last earnings report?
Torii Pharmaceutical Co reported an EPS of ¥49.51 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.115%.
Which hedge fund is a major shareholder of Torii Pharmaceutical Co ?
Currently, no hedge funds are holding shares in JP:4551
Company Description
Torii Pharmaceutical Co
Torii Pharmaceutical Co (4551) is a Japanese pharmaceutical company engaged in the research, development, manufacture, and sale of pharmaceutical products. The company focuses on therapeutic areas including renal diseases, skin diseases, and allergy-related conditions. Torii Pharmaceutical is committed to providing high-quality pharmaceutical solutions and improving healthcare outcomes.
Technical Analysis
SAWAI GROUP HOLDINGS Co., Ltd.
―
Mochida Pharmaceutical Co., Ltd.
―
Kissei Pharmaceutical Co
―
Towa Pharmaceutical Co
―
Kaken Pharmaceutical Co
―